Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective

S. Roze J. Ferrieres E. Bruckert Eric van Ganse 1 Mj. Chapman D. Liens C. Renaudin
1 Evaluation et modélisation des effets thérapeutiques
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02307590
Contributor : Depot 1 Lyon 1 <>
Submitted on : Monday, October 7, 2019 - 4:58:00 PM
Last modification on : Thursday, October 10, 2019 - 1:24:33 AM

Links full text

Identifiers

Collections

Citation

S. Roze, J. Ferrieres, E. Bruckert, Eric van Ganse, Mj. Chapman, et al.. Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective. International Journal of Clinical Practice, 2007, 61, pp.1805-1811. ⟨10.1111/j.1742-1241.2007.01546.x⟩. ⟨hal-02307590⟩

Share

Metrics

Record views

2